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Introduction: Randomised controlled trials (RCTs) have demonstrated that anticoagulation by direct 
oral anticoagulants (DOACs) or vitamin-K-antagonists (VKAs) reduces the risk of stroke in people 
with atrial fibrillation. RCTs of DOACs demonstrated that they were non-inferior to VKAs and had a 
lower incidence of major bleeding. However, it is uncertain whether these results extrapolate to older 
people who were under-represented in these trials. This abstract describes the development of a protocol 
for a systematic review of observational studies to investigate whether the rates of ischaemic stroke and 
major bleeding differ between older patients treated with DOACs and vitamin-K-antagonists. 
Methods: The research question, search, inclusion and exclusion criteria were developed iteratively 
using the PICOS acronym as the base: 
Population– People aged over 75 with atrial fibrillation 
Intervention– DOACs 
Comparator– Vitamin K antagonists 
Outcomes– Stroke and major bleeding 
Study design– Observational studies 
Results: A systematic review protocol of observational studies was derived and registered with 
PROSPERO (CRD42018081696). The primary outcomes to be assessed were effectiveness (ischaemic 
stroke prevention) and safety (bleeding). In outline, Medline, EMBASE, Scopus and Web of Science 
will be searched from 2009 to present. Reference list searches will be used to identify further relevant 
studies. Manufacturers of DOACs will be contacted to request unpublished data. Data will be extracted 
independently by two reviewers using a pre-piloted form. Study data will be quantitatively synthesised 
and standard meta-analyses will be undertaken for each pair of treatment comparisons. Preliminary 
database searches have identified 13,623 citations. From abstract and title review it is expected that 400 
will be eligible for full text review. 
Conclusions: This systematic review of observational data will complement the evidence from RCTs 
to provide an insight into the effectiveness and safety of these medications in older patients who have 
historically been be underrepresented in clinical trials. The findings of this review will provide 
important information for patients and practitioners alike. 
